The diabetic-subgroup meta-analysis points toward harm (both bounds near or above the null), unlike the general-population null — a ‘for whom’ signal, though heterogeneity is considerable and CIs touch 1.0.
The diabetic-subgroup meta-analysis points toward harm (both bounds near or above the null), unlike the general-population null — a ‘for whom’ signal, though heterogeneity is considerable and CIs touch 1.0.